Home
For Consumers

Home
For Consumers

FD19298_Nyxoid_HCP LBH_8pp_A4_D4 PDF

02 Dec FD19298_Nyxoid_HCP LBH_8pp_A4_D4 PDF

Posted at 05:05h in by Rob Bates 0 Comments

0 Likes

FD19298_Nyxoid_HCP LBH_8pp_A4_D4 PDF

No Comments

Post A Comment

Save my name, email, and website in this browser for the next time I comment.

Mundipharma Pty Limited, Sydney // Privacy Policy // Terms of Use // Contact Us // NYXOID^® is a registered trade mark of MUNDIPHARMA.

NYXOID^® is not a substitute for emergency medical care. Call 000 immediately before administering naloxone. Additional doses may be required until emergency medical treatment arrives. Ask your pharmacist at the time of purchase.

Ask your pharmacist - they must decide if this product is right for you

The Australian Government is investing $19.6 million over 4 years from 2022-23 to deliver the Take Home Naloxone (THN) program nationally. From 1 July 2022, naloxone is available for free with no prescription. This is for anyone who may experience, or witness, an opioid overdose or adverse reaction. To find out more please click here.

© Website Design by Wise Up Marketing AU-NYX-2400001 Oct 2024